Boston Scientific Corporation has entered a definitive agreement to acquire the remaining 74% stake not yet owned in Bolt Medical, in a deal valued at up to $664m. The acquisition includes nearly ...

Boston Scientific Corporation today announced it has entered into a definitive agreement to acquire Bolt Medical, Inc., the developer of an intravascular lithotripsy (IVL) advanced laser-based ...

Boston Scientific (BSX) announced it has entered into a definitive agreement to acquire Bolt Medical, the developer of an intravascular lithotripsy advanced laser-based platform for the treatment ...

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Is Boston Scientific (BSX) one of those stocks right now? A quick glance at the ...

Boston Scientific acquires Bolt Medical for $443 million upfront, with up to $221 million contingent on regulatory milestones. Bolt IVL platform uses acoustic waves to treat calcified artery ...

Farapulse, Boston Scientific’s pulsed field ablation product, fueled year-over-year growth of nearly 171% in the fourth ...

Boston Scientific (NYSE:BSX) announced on Wednesday the acquisition of the ~74% stake in Bolt Medical that the medical devices company does not already own. BSX shares were trading +2.07% pre ...

Medical device maker Boston Scientific forecast annual profit above Wall Street estimates on Wednesday, banking on steady demand for its heart devices.

(RTTNews) - Boston Scientific Corp. (BSX) announced on Wednesday its agreement to acquire the remaining 74 percent stake in Bolt Medical, Inc., which it does not already own, for approximately $ ...

Boston Scientific (NYSE:BSX – Get Free Report) had its price objective lifted by equities research analysts at Raymond James ...

On Wednesday, Boston Scientific Corporation (NYSE:BSX) agreed to acquire Bolt Medical, Inc., the developer of an intravascular lithotripsy (IVL) advanced laser-based platform for coronary and ...